Skip to main content
. 2014 Jul 24;2014:560491. doi: 10.1155/2014/560491

Figure 3.

Figure 3

Effects of candesartan alone and in combination with FeTPPS and GM6001 on infarct size (a, d), edema (b, e), and hemoglobin content (c, f) at 24 h after MCAO. Infarct size and Hb content were significantly reduced in all three treatment groups in FeTTPS compared to the saline treated group (# P < 0.05). Candesartan alone and in combination with GM6001 did not reduce these outcomes when administered with DMSO, but GM6001 alone resulted in a significantly reduced infarct size. Values are mean ± SEM (# P < 0.05).